Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concerta in Swedish male prison inmates with ADHD
NCT00482313Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- May 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methylphenidate osmotic release oral system in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Conners Adult ADHD Rating Scale at 5 weeks. Started May 2007; status: completed.
02
Drugs
methylphenidate osmotic release oral system
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00482313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482313.